Here’s a structured collection of FAQs tailored for academic researchers working with SLAC1 antibodies, organized by complexity and methodological focus:
Experimental design:
Data interpretation: Use a signaling pathway table to contextualize results:
| Pathway | Key Regulators | SLAC1 Current Amplitude (nA) | Citation |
|---|---|---|---|
| Ca²⁺-independent | OST1, ABI1 | 450 ± 60 | |
| Ca²⁺-dependent | CPK21, CPK23 | 320 ± 45 | |
| Phosphomimetic | S59D/S107D/S152D | 620 ± 80 |
Target non-conserved extracellular loops (e.g., residues 105–112 in the latch domain) to avoid cross-reactivity with homologs like SLAH3 .
Avoid epitopes near phosphorylation sites (e.g., S59, S107, S152) to prevent antibody interference with kinase assays .
Use surface plasmon resonance (SPR) to quantify antibody binding affinity to SLAC1 extracellular domains (KD < 1 nM recommended) .
Step 1: Optimize membrane solubilization with 2% (w/v) digitonin to preserve SLAC1-kinase complexes .
Step 2: Employ 2D gel electrophoresis to separate SLAC1 isoforms by charge (phosphorylation alters pI by ~0.5 units) .
Step 3: Validate with kinase inhibitor assays (e.g., 10 μM staurosporine) to confirm phosphorylation-dependent mobility shifts .
Methodology:
Perform bimolecular fluorescence complementation (BiFC) with SLAC1-YFPᶜ and ABI1-YFPᴺ in guard cell protoplasts .
Quantify interaction strength using fluorescence lifetime imaging microscopy (FLIM) to detect FRET efficiency changes .
Correlate with anion current measurements: Functional ABI1-SLAC1 binding should reduce OST1-activated currents by ≥70% .
Resolution: Antibody-antigen complex should resolve ≤3.5 Å to visualize latch/plug domain rearrangements .
Epitope stability: Epitopes must withstand grid freezing conditions (e.g., 0.1% glutaraldehyde for 30 s).
Validation metric: Antibody should recover ≥90% of SLAC1 channels in single-particle analysis from native membranes .